Testosterone Update

is a unique CME-certified initiative committed to alleviating the symptoms of patients

suffering from hypogonadism, through accurate diagnosis and reestablishment of constant physiologic testosterone levels, for improved overall health and well-being.


	Clinical Consult Martin M. Miner, MD, answers your question about hypogonadism: How do injectable and transdermal testosterone therapies for hypogonadism impact associated psychological symptoms?

	*Disease State Theater at AUA Annual Meeting* During the AUA Annual Meeting, visit Booth #2119 for live and interactive presentations from experts in the field of hypogonadism.

	Polling Question Please take a moment to answer the following question: Which adverse event would cause you to discontinue a patient’s testosterone therapy?


	Proceedings From the TU 1st Annual Conference on Improving Clinical Outcomes in Hypogonadism Physicians at the forefront of treatment and research presented and discussed the newest data regarding hypogonadism and testosterone therapy. To request a copy of this proceedings paper, please click here.

	Esource Presentation Builder This feature allows members to create their own PowerPoint^® presentations online by selecting slides from several modules, including epidemiology, diagnosis and assessment, clinical management and monitoring of the prostate, and current and novel therapeutic options. These slides were specifically developed as a resource for health care professionals interested in hypogonadism who need customized presentations for speaking engagements.




	Emerging Evidence and Future Directions in Treating Hypogonadism This informative monograph is co-authored by Adrian S. Dobs, MD, MHS, and Frances J. Hayes, MD.

	*Optimizing Patient Safety in the Management of Hypogonadism* This satellite symposium was presented at the 16th Annual Meeting and Clinical Congress of the American Association of Clinical Endocrinologists. Earn up to 1.5 AMA PRA Category 1 Credits™ by participating online.

	*Bridging the Treatment Gaps in the Management of Hypogonadism* In this paper, faculty address issues facing clinicians who treat men with hypogonadism. Read this CME-certified paper and apply for a maximum of 1.5 AMA PRA Category 1 Credits™.

	E *source Current Data and Considerations: Novel Testosterone Formulations* The 4 modules of the TU Esource slide set and the 2 focused slide presentations are available with lecture notes. View and download the Esource slides to create or enhance your own presentation about the treatment of hypogonadism.

	CAUSE education (Collaborative for Advancement of Urologic • Sexual • Endocrine education) CAUSE education is a multifunded educational initiative for urologists, endocrinologists, primary care clinicians, and allied health professionals. Under the guidance of the expert Steering Committees, the collaborative develops and distributes cutting-edge CME-certified materials on erectile dysfunction, hypogonadism, and sexual dysfunction. As its name denotes, CAUSE education advocates a multisystem and multidisciplinary approach to men’s overall well-being and sexual health.

New Member Opportunity: Would you like to be considered to be a Presenting Faculty Member?
Please click here to complete the form and to submit your CV for review.